NIDDK Central Repository - Investigation of Adducin 2 (beta) DNA polymorphisms in genetic predisposition to diabetic nephropathy in Type 1 diabetes.

An official website of the United States government

NIDDK Central Repository

Publication Information

DOI

10.1111/j.1464-5491.2008.02511.x

PubMed ID

18959617

Public Release Type

Journal

Publication Year

2008

Affiliation

Nephrology Research Group, Queen's University of Belfast, Belfast, Northern Ireland, UK.

Authors

Bain S, Boulton AJ, Currie D, Demaine A, Marshall S, Maxwell A, Maxwell AP, McKnight A, McKnight AJ, Millward B, Sadlier D, Savage D, Thomas S, Viberti G, Walker J, Warren 3/UK GoKinD Study Group

Studies

GoKinD

Citation

Currie D, Maxwell AP, Sadlier D, McKnight AJ, Warren 3/UK GoKinD Study Group. Investigation of Adducin 2 (beta) DNA polymorphisms in genetic predisposition to diabetic nephropathy in Type 1 diabetes. Diabet Med 2008 Aug;25(8):1001-5.

Abstract

Adducin 2 (beta) (ADD2) is a biological and positional candidate gene proposed to confer genetic risk for diabetic nephropathy. This study aimed to comprehensively investigate all common and putatively functional polymorphisms in the genomic region encompassing this gene.